Skip to main content
  • TEER Shows Durable Outcomes, Comparable Survival to Tricuspid Valve Surgery at 1 Year in Primary TR: Registry Analysis

    In patients with symptomatic, severe primary tricuspid regurgitation (TR), transcatheter edge-to-edge repair (TEER) and isolated tricuspid valve surgery showed comparable 1-year survival, and TEER’s procedural safety and efficacy outcomes were sustained through 1 year, a new registry analysis shows. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details